EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Synergistic Anti-Zika Activity of Repurposed Statin and Clofibrate Combinations: Evidence from Oleic Acid-Mediated Metabolic Complementation

Chung-Do Lee iD, Sang-Ik Park iD, Gun Lee iD, Hyeon Jeong Moon iD, Jaewoo Choi, Jun Bong Lee, Luis Martinez-Sobrido iD, Fernando Almazán iD, Eun-Hye Ryu, Yeong-Bin Baek iD, Jun-Gyu Park iD

International Journal of Molecular Sciences · 2026

DOI: 10.3390/ijms27219637 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Chung-Do Lee und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pathology, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju 61186, Republic of Kor…. Hauptthemen laut MEDLINE: Clofibrate, Antiviral Agents, Hydroxymethylglutaryl-CoA Reductase Inhibitors, Zika Virus. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Ministry of Education, Ministry of Education (MOE) and Jeonnam-Gwangju Special Metropolitan City, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Zika virus (ZIKV) substantially relies on host lipid metabolism, presenting a prime target for host-directed antivirals. To identify host-directed antiviral interventions while circumventing interferon-mediated transcriptomic masking, we curated a dual-virus (dengue and ZIKV) gene signature to query the Connectivity Map. Top lipid-lowering candidates were validated using a reporter virus (rZIKV-Venus) and an authentic wild-type (WT) ZIKV in Vero E6 cells—a model deliberately selected for its interferon deficiency to isolate pure metabolic responses. Dose–response screening of 67 prioritized compounds identified atorvastatin, rosuvastatin, and clofibrate as potent ZIKV inhibitors. Statin–clofibrate combinations exhibited strong synergy, with fractional inhibitory concentration index (FICI) values of 0.203 (atorvastatin–clofibrate) and 0.117 (rosuvastatin–clofibrate) for the 4:1 clofibrate-to-statin ratio and an optimized selectivity index. Mechanistically, exogenous oleic acid supplementation induced significant metabolic complementation, significantly restoring both host lipid droplet (LD) abundance and ZIKV replication readouts suppressed by the dual treatment. Relative LD intensity strongly correlated with viral intensity in both models (Pearson r = 0.951 and 0.956, respectively; both p < 0.0001). These findings demonstrate that concurrent pharmacological modulation of host lipid metabolism exerts synergistic anti-ZIKV effects, highlighting highly curated transcriptomic repurposing as a mechanistic prioritization strategy for host-directed antiviral discovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ClofibrateAntiviral AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsZika VirusOleic AcidAnimalsVero CellsDrug SynergismChlorocebus aethiopsVirus ReplicationDrug RepositioningDengue VirusRosuvastatin CalciumHumansAtorvastatinLipid Metabolism

Stichwörter der Autor:innen

Zika virusclofibratedengue virusdrug repurposinghost-directed antiviralimmunometabolismlipid dropletmetabolic complementationstatin

Substanzen

ClofibrateAntiviral AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsOleic AcidRosuvastatin CalciumAtorvastatin

Autor:innen und Institutionen

  • Department of Veterinary Pathology, College of Veterinary Medicine and BK21 FOUR Program, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Animal Medical Institute, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Department of Veterinary Pathology, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Department of Food and Environmental Hygiene, College of Veterinary Medicine, Chonnam National University, Gwangju 61186, Republic of Korea.
  • Texas Biomedical Research Institute, San Antonio, TX 78227, USA.
  • Centro Nacional de Biotecnología (CNB-CSIC), Darwin 3, Campus Cantoblanco UAM, 28049 Madrid, Spain.

ORCID-Profile: Chung-Do Lee, Sang-Ik Park, Gun Lee, Hyeon Jeong Moon, Luis Martinez-Sobrido, Fernando Almazán, Yeong-Bin Baek, Jun-Gyu Park

Förderung

  • National Research Foundation of Korea
  • Ministry of Education
  • Ministry of Education (MOE) and Jeonnam-Gwangju Special Metropolitan City, Republic of Korea

Zitieren

APA

Lee, C. D., Park, S. I., Lee, G., Moon, H. J., Choi, J., Lee, J. B., Martinez-Sobrido, L., Almazán, F., Ryu, E. H., Baek, Y. B., & Park, J. G. (2026). Synergistic Anti-Zika Activity of Repurposed Statin and Clofibrate Combinations: Evidence from Oleic Acid-Mediated Metabolic Complementation. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219637

Vancouver

Lee CD, Park SI, Lee G, Moon HJ, Choi J, Lee JB, et al. Synergistic Anti-Zika Activity of Repurposed Statin and Clofibrate Combinations: Evidence from Oleic Acid-Mediated Metabolic Complementation. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219637

BibTeX
@article{Lee2026,
  author = {Lee, Chung-Do and Park, Sang-Ik and Lee, Gun and Moon, Hyeon Jeong and Choi, Jaewoo and Lee, Jun Bong and Martinez-Sobrido, Luis and Almazán, Fernando and Ryu, Eun-Hye and Baek, Yeong-Bin and Park, Jun-Gyu},
  title = {Synergistic Anti-Zika Activity of Repurposed Statin and Clofibrate Combinations: Evidence from Oleic Acid-Mediated Metabolic Complementation},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  doi = {10.3390/ijms27219637}
}
Kostenlos starten →